Three-dimensional quantitative structure-activity relationship (3D-QSAR) studies were performed on a series of substituted 1,4-dihydroindeno[1,2-c]pyrazoles inhibitors, based on molecular docking scores obtained by using 
Introduction
DNA-damaging anticancer agents is the mainstay of cancer treatment and has produced significant increases in the survival of cancer patients when used in combination with drugs that have different mechanisms of actions [1] .However, the clinical use of DNA-damaging anticancer agents is limited by their severe toxicity and by resistance from tumor cells. So, it is important to develop highly efficacious and minimally toxic treatments for cancer. Recently, the development of adjuvant therapeutics has been aggressively pursued. Such treatments may either sensitize tumor tissue or protect normal tissue from DNA damage [2] .
With DNA damage, cells are arrested (G1, S, G2) to initiate the DNA repair process [3] [4] [5] . Most tumor cells distinguish themselves from normal cells by lacking the G1 checkpoint due to loss of p53, and therefore they are selectively arrested at the S or G2 checkpoint after DNA damage. If the S and 
COMPUTATIONAL DETAILS

Biological Data and Molecular Structures
We gathered a panel of 151 structurally and pharmacologically diverse compounds for the 3D QSAR analysis from four publications reported by one laboratory [2，11，14-15] .Because of the similar experimental procedures applied for affinity determination in each publication, the biological data (represented as IC 50 values) were considered comparable and thus merged into our study. The IC 50 values, in nM, were converted to pIC 50 (-log IC 50 ) values, which were used as dependent variables in the QSAR analyses. The biological data were divided into a training set and a testing set as shown in Table 1 , 2 and 3. The training set which was selected randomly consists of 121 compounds and the testing set is comprised of 30 compounds.
The 3D structures of these compounds were carried out on a personal computer with the RHEL 4.0 operating system using SYBYL 8.0. The 3D structures of the training and test set of compounds were constructed using the Sketch Molecule function in SYBYL. Partial atomic charges were calculated by the Gasteiger-Hückel method and energy minimizations were performed using the Tripos force field with a distance-dependent dielectric and the Powell conjugate gradient algorithm (convergence criterion of 0.005 kcal/mol/Å).
Docking Studies
For the docking of ligands to protein active sites and for estimating the binding affinities of docked compounds, an advanced molecular docking program GOLD version 3.01 , with a powerful genetic algorithm (GA) method for conformational search and docking programs, was used in this study. for the number of subpopulations, 100000 for the maximum number of genetic applications, and 2 for the size of the niche used to increase population diversity. The weights were chosen so that crossover mutations were applied with equal probability (95/95 for the values), and migration was applied 5% of the time. ChemScoring function encoded in GOLD was applied to predict binding positions between CHK1 and 150 inhibitors. The fitness score is taken as the negative of the sum of the component energy terms, so that larger fitness scores are better [12] .
Structural alignment
Molecular alignment is the most sensitive parameter in 3D-QSAR analysis. This renders the spatial alignment of molecules under study as one of the most sensitive and determining factors in obtaining robust and meaningful models. Ten conformations were obtained using GOLD for each ligand, in which the training set contained the conformations with the top-ranked ChemScores while the test set contained the conformations with the lowest residues between actual and predicted pIC 50 predicted by the CoMFA model of the training set. 121 inhibitors were selected randomly as the training set, and these inhibitors were aligned together for CoMFA study to explore the specific contributions of electrostatic and steric effects of the molecular bioactivities.
CoMFA
Steric and electrostatic interactions were calculated using the Tripos force field with a distance-dependent dielectric constant at all intersections in a regular space (2 Å) grid taking a sp 3 carbon atom as steric probe and all charge as electrostatic probe. The cutoff was set to 30 kcal/mol.
With standard options for scaling of variables, the regression analysis was carried out using the full cross-validated partial least-squares (PLS) method of LOO (leave-one-out). The minimum-sigma (column filtering) was set to 2.0 kcal/mol to improve the signal-to-noise ratio by omitting those lattice points whose energy variation was below this threshold. The final model, a non-cross-validated conventional analysis, was developed with the optimum number of components to yield a non-cross-validated r 2 value [13] .
Results and Discussion
Docking study
In order to determine the probable binding conformations of these substituted 1,4-dihydroindeno[1,2-c]pyrazoles , GOLD was used to dock all compounds into the active sites of CHK1. The docking reliability was validated using the known X-ray structure of CHK1 in complex with a small molecular ligand CHK2759M41. The ligand CHK2759M41 was redocked to the binding suggesting that a high docking reliability of GOLD in reproducing the experimentally observed binding mode for CHK1 inhibitors and the parameters set for the GOLD simulation was reasonable to reproduce the X-ray structure. Just as shown in Figure 2 , the cocrystallized CHK2759M41 and redocked CHK2759M41 are almost at the same position in the active sites of CHK1. Therefore, the GOLD method and the parameters set could be extended to search the CHK1 binding conformations for other inhibitors.
The predicted binding free energies (ChemScore) for all the inhibitors are listed in Table 2 
CoMFA model
The CoMFA analysis was performed to explore the structure-activity relationship of substituted 1,4-dihydroindeno[1,2-c]pyrazoles inhibitors of CHK1. PLS analysis was carried out for the 121 training set, and the result is listed in Table 4 , which showed that a CoMFA model with a cross-validated q 2 of 0.534 for 6 components was obtained. The CoMFA steric contours of the most active molecule CHK2759M41 is displayed in Figure 7 .
A large green region (G1) near the 6-position of CHK2759M41 indicates that a bulky substituent is preferred in the position to produce higher inhibitory activity. This is in agreement with the fact that the inhibitory activities of compounds CHK2759M38 and CHK2759M42 with more bulky substituents ( with aliphatic hydrocarbon )in G1 are higher than compound CHK3618M5（-H）. Also, compounds CHK2759M39 and CHK2759M41, which are cyclohexane analogues, showed higher activity than compound CHK3618M5（-H）.And that cyclohexane ring interacts with the hydrophobic surface of the side chains of Tyr86, Ser88, Thr14, Asp94 and Glu17. So this volume (G1) is in agreement with the receptor structure.
Two yellow contours (Y1, Y2) were observed which suggest that compounds with substituents entering these contours are less active than those with substituents that do not entering these contours. Figure 3 shows that residues Phe149, Glu55, Lys38 and Leu84 in the binding pocket of the CHK1 are in the distance of less than 3.0 Å to Y1 and Y2 of these inhibitors. Therefore, any larger substitutes may lead to steric collision with those residues in the pocket. One finding lend further support to this opinion, the activity of compound CHK2759M41 decreases quickly after the -OH groups are replaced by bulky groups, just like CHK2759M31 which has benzene ring group in Y1 and Y2 .
Due to the steric collision with these residues in Y1 and Y2, those compounds move downward and the hydroxybenzenes of those compounds entering into the large green contour map(G3).This large region of green contour (G3) around the 3-position of the CHK2759M41 suggests that steric bulk is favourable there. For example, the activity of compounds CHK5944M23 and CHK5944M24 (with abenzene ring) are higher than compound CHK5944M22 (with a acetylene).It can be see in Figure 3 that the benzene ring interacts with the hydrophobic surface of the side chains of Leu84, Ile56, Val56
and Phe149. So this region (G3) is in agreement with the receptor structure.
The electrostatic contour map of the CoMFA model is shown in Figure 8 . To facilitate the visualization, the most potent compound CHK2759M41 is overlaid on the map.
R1 suggests that electronegative groups at this position are favourable for inhibitory activity. For example, the high active compounds CHK2758M22，CHK2758M23，CHK2758M24，CHK2758M25， CHK2758M26，CHK2758M27 and CHK2758M28 have electronegative groups (carboxy) located in this red contour. As indicated in Figure 3 , Lys38 which containing positive groups in this region (R1), has a strong electrostatic interaction with the negative charged groups (carboxy) of those inhibitors.
Two red contours (R2, R3) observed next to the plane of the benzene ring are contributed by the nitrile group in compounds CHK5944M40 to CHK5944M50 and are taken as an indication of the role of electronegative groups at these positions in increasing the inhibitory activity. Nitrile groups have an overall negative-charge and hence show reasonable activity. Furthermore, Asn59 containing positive groups rather near this region (R2, R3), has a strong electrostatic interaction with the negative charged substitute groups of the inhibitors. Also, the hydrogen in the -NH group is electrophilic, further docking study showed that the -NH groups of Asn59 or Phe149 might form H-bonds with the -OH groups of CHK4308M5-CHK4308M52.
Two large blue (B1 and B2) regions near Glu55, Gly150 and Asp148 suggest that electropositive substituents would increase the inhibitory activity. Those residues have a hydroxyl. The docking result of the potent inhibitor CHK2759M41 showed that the hydroxyl groups of CHK4308M5 to CHK4308M52 donated a hydrogen bond to Glu55.
A large blue contour (B3) is noticed in 6-position of CHK2759M41. As show in Figure 9 , a small In Figure 10 , the blue contour region (B5) shows that electropositive groups are favourable in this region. Inhibitors 42 and CHK3618M24 which contain partially positive charged groups (methyl) in this region show higher pIC 50 values.
Validation of the 3-D QSAR Models
The thirty randomly selected compounds (Table 3) were used as the testing set to verify the constructed CoMFA model. The calculated results are listed in Table 3 and displayed in Figure 7 . 
Conclusions
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Discovery of 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-benzonitriles and 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-pyridine-2'-carbonitriles as potent checkpoint kinase 1 (Chk1) inhibitors,
